Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
92 Cards in this Set
- Front
- Back
Tamoxifen may cause increased risk of what cancer?
|
uterine
|
|
Aromatase inhibitors as treatment/prevention of breast cancer are only effective for whom?
|
post-menopausal women
|
|
Lifetime cancer risks for men and women with Li-Fraumeni
|
women=90%
men=70% |
|
What childhood cancers are the hallmark sign of Li-Fraumeni? What is the most predictive tumor of the syndrome?
|
childhood sarcomas of any type
childhood adrenocortical tumors |
|
Features of Cowden syndrome
|
macrocephaly
trichilemmomas and papillomatous papules breast, follicular thyroid, and uterine cancers Llermitte-Duclose disease--benign brain tumor--hydrocephalus? |
|
Benign tumors associated with Cowden syndrome
|
papillomatous papules
trichilemmomas thyroid lesions hamartomatous intestinal polyps lipomas fibromas of uterine, breast, etc. |
|
Cancers assoc. with HNPCC
|
early-onset colon cancer, endometrium, ovary, small bowel, stomach, pancreas, ureter, renal pelvis
|
|
What type of thyroid cancer is associated with FAP?
|
papillary thyroid cancer
|
|
Cancers assoc. with FAP
|
adenomatous polyposis, colorectal cancer, papillary thyroid cancer, gastric cancer, periampullary carcinoma, adrenal cancer, hepatoblastoma and extracolonic manifestations
|
|
Features of Gorlin syndrome
|
basal cell nevi, characteristic facies, palmar and plantar pits, odontogenic keratocysts, rib abnormalities, increased risk of basal cell carcinoma, ovarian carcinoma, ovarian fibromata
|
|
Genes assoc. with Li-Fraumeni
|
p53, CHEK2
|
|
Cancers assoc. with Peutz-Jehgers
|
breast cancer, benign ovarian tumors, testicular tumors, pancreatic cancer, hamartomatous polyps of ureterm, GI tract, bladder, renal pelvis, bronchus, nasal passage. Melanin spots on lips, inside mouth, and on digits
|
|
Genes assoc. with Peutz-Jeghers
|
STK11, LKB1
|
|
Findings of von Hippel -Lindau
|
Hemangioblastomas of brain, retina, spine; pheochromocytomas, renal cell carcinoma, epididymal cystadenoma, endolymphatic sac tumors
|
|
Findings of MEN2A
|
medullary thyroid carcinoma
pheochromocytoma parathyroid tumors/parathyroid hyperplasia |
|
Findings of MEN2B
|
early-onset medullary thyroid carcinoma
early pheochromocytoma mucosal neuromas Marfanoid habitus |
|
other cancers associated with RB1
|
sarcoma, lung
|
|
Genes assoc. with juvenile polyposis syndrome
|
SMAD4/DPC4
|
|
Carcinoma is cancer of what type of tissue?
|
endoderm or ectoderm-derived epithelial or skin tissue
|
|
What % of germline retinoblastoma cases have a family history?
|
20%
|
|
Penetrance of retinoblastoma
|
90%
|
|
Cowden syndrome--lifetime risk of breast cancer
|
25=50%
|
|
Cowden syndrome--lifetime risk of thyroid cancer
|
10%
|
|
Cowden syndrome--lifetime risk of uterine cancer
|
5-10%
|
|
What is the Founder mutation of CHK2, and where is this most common?
|
1100delC
Netherlands and Finland |
|
Findings of Proteus syndrome
|
connective tissue nevi
disproportional overgrowth lipomas or absence of fat vascular malformation facial phenotype |
|
Name 2 low-penetrance breast cancer genes
|
ATM
CHK2 |
|
Of hereditary ovarian cancer, what % is due to BRCA1?
BRCA2? HNPCC? other single genes? |
BRCA1=70%
BRCA2=20% HNPCC-2% other=8% |
|
Risk factors for colorectal cancer
|
aging
personal history of colorectal cancer or adenomas high fat, low fiber diet inflammatory bowel disease family Hx hereditary colon cancer syndromes |
|
Up to what percent of people with FAP have de novo germline mutations?
|
30%
|
|
FAP--do most families have unique mutations, or the same few?
|
unique
|
|
In FAP, where else might patients have tumors?
|
upper GI, desmoid, osteoma, thyroid, brain, hepatoblastoma
|
|
Features of Gardner syndrome
|
FAP plus desmoid tumore, CHRPE, osteomas, extra teeth, soft tissue skin tumors
|
|
Features of Attenuated FAP
|
later onset-50s
few colonic adenomas--more than 20, less than 100 no CHRPE may have upper GI lesions 5' and 3' end mutations in APC |
|
Clinical management for FAP
|
annual colonoscopy until polyposis
colectomy annual upper endoscopy chemoprevention monitoring for desmoids, etc. genetic testing for others in family |
|
chemoprevention for FAP
|
Celebrex, Sulindac, others
|
|
The founder FAP mutation in Ashkenazi Jews
|
I1307K
|
|
Why is the AJ founder FAP mutation (I1307K) controversial?
|
Some report no increased risk
|
|
Average age of recessive MYH-associated colon cancer
|
50s
|
|
How many polyps usually present with recessive MYH-associated colon cancer?
|
more than 15, but not THAT many
|
|
2 common MYH mutations causing recessive colon cancer.
What population gets these? |
Y165C
G382D European |
|
Of all colon cancer, what % is caused by HNPCC?
|
about 2%
|
|
Extracolonic cancers assoc. with HNPCC
|
endometrial, stomach, ovarian, pancreas, ureter, renal pelvis, biliary tract, glioblastoma (Turcot), keratoacanthomas (Muir-Torre), sebaceous gland adenomas
|
|
Risk of colorectal cancer in HNPCC
|
70%
|
|
Risk of endometrial cancer in HNPCC
|
43-60%
|
|
Name the Amsterdam criteria for HNPCC.
|
3 or more relatives with verified CRC in family
one case in a first degree relative of the other 2 cases 2 or more generations affected One CRC by age 50 FAP excluded *Failure to exclude does NOT exclude HNPCC* |
|
Revised Bethesda guidelines for HNPCC: MSI testing should be done when 1 or more of what guidelines exist?
|
1. CRC in pt under 50
2. Presence of 2 CRCs, or CRC plus other assoc. cancer, in one person, regardless of age 3. CRC that is MSI high or under age 60 4. CRC or assoc. tumor in at least 1 FDR under 50 5. CRC or assoc. tumor at any age in 2 first or second degree relatives |
|
What percent of sporadic tumors have MSI?
What % of HNPCC tumors have MSI? |
10-15% of sporadic tumors
95% of HNPCC tumors |
|
What is the American founder mutation in MSH2? (HNPCC)
|
deletion of exons 1-6
|
|
In HNPCC, what is significant about those with mutation in MSH6?
|
They may have a 30% less risk for colon cancer
|
|
Features of Fanconi Anemia
|
short stature
skeletal and dev. anomalies increased leukemia risk increased risk of other blood and solid cancers |
|
Fanconi anemia assoc. with BRCA2 mutations also causes increased risk of what solid cancer?
|
brain tumors
|
|
If you see polyposis in a family and it's all in one generation, what shoud you immediately think of?
|
MYH associated polyposis, which is recessive
|
|
Homozygous mutations in what gene lead to a very severe HNPCC phenotype, but cluse low penetrance or no increased cancer risk in heterozygous form?
|
PMS2
|
|
Which HNPCC gene can be assoc. with cafe au lait spots?
|
PMS2
|
|
What percent of families that meet Amsterdam criteria have no detectable HNPCC mutation or MSI?
|
up to 45%
|
|
Features of Familial Colorectal Cancer Type X
|
HNPCC-like with no identifiable mutation or MSI.
No HNPCC-associated cancers besides colon later onset lower chnce of 2nd tumors due to unknown genes |
|
What Prior Probabliity is considered reasonable for offering BRCA testing?
|
5-10%
|
|
Best known Prior Probablity model for BRCA mutation
|
Bayes Model (formerly BRCAPro)
also assess likelihood of MMR mutation and pancreatic cancer mutation |
|
Breast/ovarian cancer gene other than BRCA1/2
|
RAD51
|
|
Describe the basis of PARP inhibitor therapy
|
PARP is an enzyme in DNA base excision repair. BRCA1/2 mutant cells still have this type of repair. Inhibiting it causes the cell to die, sparing normal cells.
|
|
BRCA1/2 mutant cells are deficient in what type of DNA repair?
|
homologous recombination DNA repair
|
|
2 Breast cancer aromatase inhibitor trial studies
|
WISE, GOSS
|
|
Choroid plexus tumors are strongly assoc. with what cancer syndrome?
|
Li-Fraumeni (p53)
|
|
4 low penetrance breast cancer genes (new findings)
|
CHK2 1100delC
PALB2 ATM BRIP1 |
|
Up to what percent of FAP mutations are de novo germline mutations?
|
up to 30%
|
|
Lifetime risk of colorectal cancer for a person with inflammatory bowel disease
|
15-40%
|
|
Function of normal MYH protein
|
base-excision repair
|
|
Carrier freq. for MYH mutations
|
about 1%
|
|
Onset of colon cancer for MYH
|
50s
|
|
Other cancers assoc. with MYH
|
duodenal
ovarian bladder skin (even sebaceous gland tumors, like Lynch) |
|
Features of Lynch-associated colon cancer
|
right sided
onset before 50 signet ring mucinous tumor-infiltrating lymphocytes medullary pattern |
|
Cancers assoc. wtih Juvenile polyposis syndrome
|
colon cancer (39%)
gastric cancer (21%) small bowel |
|
Recommended mgmt for hereditary diffuse gastric cancer
|
prophylactic total gastrectomy at age 20
|
|
Most common type of renal cell carcinoma?
|
clear cell (70-80%)
chromophile-papillary (10-15%) |
|
Key difference btwn hereditary and sporadic renal cell carcinoma
|
hereditary=multifocal, bilateral, early-onset
sporadic=solitary, dx after age 60 |
|
Name 4 syndromes assoc.w ith renal cell carcinoma
|
von Hippel-Lindau
Hereditary Papillary Renal Carcinoma Birt-Hogg-Dube Hereditary Leiomyomatosis and Renal cell cancer |
|
How sensitive is genetic testing for von Hippel-Lindau?
|
nearly 100%
|
|
What % of von Hippel-Lindau is sporadic?
|
20%
|
|
Most common tumors in von Hippel-Lindau
|
hemangioblastomas-benign
|
|
Locations of hemangioblastomas in von Hippel-Lindau
|
cerebellum (80%)
retina (40%) spine (20%) |
|
What % of VHL patients get endolymphatic sac tumors (ears)?
|
10%
|
|
Pheochromocytoma is associated with which renal cell carcinoma syndrome? How can this affect diagnosis?
|
VHL
Adrenal glands produce only noradrenaline. Biochem analysis of adrenaline and noradrenaline can lead to diagnosis. |
|
Screening for VHL
|
Full MRI of brain and spine at 11
Eye exam annually in childhood MRI/CT scan for abdominal tumors Biochem screening |
|
Features of hereditary papillary renal carcinoma
|
bilateral, multifocal
onset usually 50-70 only affects kidney due to activation of proto-oncogene c-MET |
|
Gene assoc. With Hereditary papillary renal carcinoma
|
c-MET
|
|
What syndrome is assoc. with quadriradial figures of the chromosomes? What cancer is assoc. with this syndrome?
|
Fanconi pancytopenia
AMML squamous cell |
|
Features of Nijmegen breakage syndrome
|
short stature, microcephaly, normal IQ with regression, sloping forehead, micrognathia, long nose, recurrent infections, anemia, thrombocytopenia, multiple tumor types. NBS1 gene (nibrin)
|
|
What syndrome?
sparse colon polyps hypopigmented macules frontal balding ridged and pigmented nails |
Cronkhite-Canada syndrome
colonic polyposis with alopecia and nail pigmentation, without family history or risk of malignancy |
|
3 regions of the chromosomes assoc. with Hereditary Dysplastic Nevus syndrome (FAMMM)
|
1p
9p 12q |
|
What are Wermer and Sipple syndromes?
|
Wermer = MEN1
Sipple =MEN2 |
|
What is TAR syndrome?
|
Thrombocytopenia, Absent radius syndrome
radial aplasia, normal thumbs thrombocytopenia at 2 months-4 years jaw hypoplasia septal cardiac defects autosomal recessive |